DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Montgomery County is attributing a dramatic decline in drug deaths to efforts to prevent them, including availability of a ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

Kindeva manufactures nasal-based drugs. It celebrated the opening of its new building and recent expansion Thursday.

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

Kindeva Drug Delivery, located off of Newtown Pike and Citation Boulevard, specializes in manufacturing life-saving ...

The recommended dose of Atzumi is 5.2mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal ...

The Trump administration has proposed terminating a $56 million annual grant program that distributes naloxone, also known by ...

A budget proposal from President Donald Trump’s administration would cut a federal grant that provides $56 million annually ...

Californians can now buy opioid reversal drugs directly from the state under a program aimed at making the life-saving ...

When Samuel Hockey's doctor suggested he try using a form of ketamine to treat his depression, he was curious."I sort of ...